Qiagen anchors drug discovery agents in curated data
Qiagen is building its drug discovery AI platform on a foundation of human-curated biomedical knowledge rather than relying solely on AI models. The company's b...
1 article
Qiagen is building its drug discovery AI platform on a foundation of human-curated biomedical knowledge rather than relying solely on AI models. The company's b...